My Cart

TLR3

TLR3 Overview

English NameToll like receptor 3Approved Drugs1
Drugs in Clinical Trials7Target SynonymCD283,TLR3,Toll Like Receptor 3,Toll-Like Receptor 3,CD283 Antigen,IIAE2
Highest Development StageApproved
English NameToll like receptor 3
Target SynonymCD283,TLR3,Toll Like Receptor 3,Toll-Like Receptor 3,CD283 Antigen,IIAE2
Approved Drugs1
Drugs in Clinical Trials7
Highest Development StageApproved

TLR3 Product List

  • Product Category

    Protein (3)Cell (1)

  • Product Status

    Launched (3)In Research (1)

  • Species

    Human (2)Mouse (1)Rhesus macaque (1)

  • Tag

    Fc Tag (3)- (1)

  • Conjugate

    Unconjugated (3)- (1)

TLR3 Synonyms

TLR3,CD283,IIAE2

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
TR-987Z-101; GLYC-101; MG-3601; TR-987Phase 3 ClinicalKazia TherapeuticsVaricose Ulcer; Varicose Veins; Wounds and Injuries
Details
Monovalent norovirus Vaccine (Vaxart)VXA-G1-1-NN; VXA-G1.1-NNPhase 2 ClinicalVaxart IncNorovirus Infections
Details
Poly ICLC (Oncovir)Phase 2 ClinicalNational Institutes Of Health, Oncovir IncBreast Neoplasms; Carcinoma, Basal Cell; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Esophageal Neoplasms; Glioma; HIV Infections; Low-grade Glioma; Lymphoma, B-Cell; Lymphoma, T-Cell; Melanoma; Mesothelioma; Metastatic breast cancer; Neoplasms; Osteosarcoma; Pancreatic Neoplasms; Prostatic Neoplasms; Sarcoma; Stomach Neoplasms; Urinary Bladder Neoplasms
Details
BO-112BO-112Phase 2 ClinicalHighlight Therapeutics SLCarcinoma, Basal Cell; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Dermatofibrosarcoma; Esophageal Neoplasms; Fibrosarcoma; Histiocytoma, Malignant Fibrous; Leiomyosarcoma; Liposarcoma; Melanoma; Neoplasms; Neurofibrosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Synovial; Stomach Neoplasms
Details
Monovalent norovirus Vaccine (Vaxart)/VXA-G2-4-NSVXA-NVV-201Phase 2 ClinicalVaxart IncNorovirus Infections
Details
CNTO-5CNTO-5Phase 1 ClinicalMorphosys AgInflammation
Details
PGV-001PGV-001Phase 1 ClinicalGenentech Inc, Icahn School Of Medicine At Mount SinaiNeoplasms; Urologic Neoplasms
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
RintatolimodAMP-516; AMP-518ApprovedHemispherx Biopharma IncRintamod, AmpligenArgentinaFatigue Syndrome, ChronicHemispherx Biopharma Inc2017-01-01Breast Neoplasms; Breast Neoplasms, Male; Colorectal Neoplasms; Fatigue Syndrome, Chronic; HIV Infections; HIV Seropositivity; Influenza, Human; Mesothelioma; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Post-Acute COVID-19 Syndrome
Details
  • Overview
  • Product List
  • Marketed Drug Information
  • Clinical Drug Information